Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
Disclaimer  Next >>
   
Security Code : 532649    Company : NECTAR LIFESCIENCES LTD.
13 Oct 2017
Compliance Certificate For The Half Year Ended On September 30, 2017.Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  13/10/2017 10:48:25         Exchange Disseminated Time   13/10/2017 10:48:28              Time Taken   00:00:03
Pursuant to regulation 7(3) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the compliance certificate for the half year ended on September 30, 2017.
 
09 Oct 2017
Compliance Under Regulation 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  09/10/2017 12:01:34         Exchange Disseminated Time   09/10/2017 12:01:41              Time Taken   00:00:07
Pursuant to Regulation 40(10)of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of said Regulations, for the half year ended September 30, 2017.
 
07 Oct 2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011Insider Trading / SASTDownload PDF
  Exchange Disseminated Time     07/10/2017 17:06:19
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv HUF
 
06 Oct 2017
Shareholding for the Period Ended September 30, 2017Company Update 
  Exchange Disseminated Time     06/10/2017 15:22:07
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here
 
04 Oct 2017
Statement Of Investor Complaints For The Quarter Ended September 30, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  04/10/2017 16:47:37         Exchange Disseminated Time   04/10/2017 16:47:46              Time Taken   00:00:09
Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statement of Investor Complaints for the Quarter ended September 30, 2017 is attached.
 
29 Sep 2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)AGM/EGM 
  Exchange Disseminated Time     29/09/2017 15:23:10
Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
 
  Scrutinizer's ReportAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  29/09/2017 13:30:09         Exchange Disseminated Time   29/09/2017 13:30:15              Time Taken   00:00:06
Please also find enclosed herewith the Consolidated Scrutinizer's Report for remote e-voting and Polling at AGM as per the provision of Section 108 and Section 109 of the Companies Act, 2013 and rules prescribed thereunder. The above is also uploaded on the website of the Company.

All resolutions were passed with requisite majority, including the resolution of declaration of Final Dividend @ Re. 0.05/- per equity share (5% on the ....
28 Sep 2017
Proceedings Of 22ND Annual General Meeting Of The CompanyAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  28/09/2017 18:25:08         Exchange Disseminated Time   28/09/2017 18:25:13              Time Taken   00:00:05
Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of Annual General Meeting held on September 28, 2017.
 
27 Aug 2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011Insider Trading / SASTDownload PDF
  Exchange Disseminated Time     27/08/2017 13:52:16
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv (HUF)
 
26 Aug 2017
  Notice Of AGM, Annual Report For 2016-17 And Remote E-Voting InstructionsAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  26/08/2017 15:04:20         Exchange Disseminated Time   26/08/2017 15:04:24              Time Taken   00:00:04
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of the Annual Report for the financial year ended on 31.03.2017 (containing notice of 22nd Annual General Meeting, Standalone financial statements, Directors and Auditors Reports thereon and Corporate Governance Report, Management Discussion and Analysis Report and consolidated ....
16 Aug 2017
Fixes Book Closure for Final Dividend & AGMAGM/EGMDownload PDF
  Exchange Disseminated Time     16/08/2017 11:57:55
Nectar Lifesciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2017 to September 28, 2017 (both days inclusive) for the purpose of Payment of Final Dividend & 22nd Annual General Meeting (AGM) of the Company to be held on September 28, 2017.
 
12 Aug 2017
Book Closure For AGM And Dividend.Corp. ActionDownload PDFDownload XBRL
  Exchange Received Time  12/08/2017 16:36:52         Exchange Disseminated Time   12/08/2017 16:36:54              Time Taken   00:00:02
Register of Members and Share Transfer Books will remain closed from 22nd September, 2017 to 28th September 2017 (Both days inclusive) for the purpose of Annual General Meeting (AGM) and dividend, if any, declared by member in the AGM. Accordingly the cut of date, to ascertain the eligibility of members for remote e-voting and polling at AGM, is September 21, 2017 i.e. the date prior to the commencement of book closure.
 
Outcome of Board MeetingBoard MeetingDownload PDFDownload XBRL
  Exchange Received Time  12/08/2017 13:19:14         Exchange Disseminated Time   12/08/2017 13:19:20              Time Taken   00:00:06
The Outcome of Board Meeting is attached.
 
Financial Results For The Quarter Ended June 30, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  12/08/2017 13:12:33         Exchange Disseminated Time   12/08/2017 13:12:38              Time Taken   00:00:05
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone Financial results for the quarter ended June 30, 2017 which are enclosed herewith along with the Limited Review Report of the Auditors thereon.

This is for your information and record.
 
04 Aug 2017
  Notice Of Board Meeting To Be Held On Saturday, August 12, 2017 And Notice Of Trading WindowBoard MeetingDownload PDFDownload XBRL
  Exchange Received Time  04/08/2017 15:20:51         Exchange Disseminated Time   04/08/2017 15:20:54              Time Taken   00:00:03
We wish to inform you that a meeting of the Board of Directors of the company will be held on Saturday August 12, 2017 to consider and approve, inter alia amongst items:

1. The Unaudited Financial Results of the Company for the Quarter ended on June 30, 2017.
2. To convene the Annual General Meeting of Members of the Company for the financial year 2016-17 and matters related thereto. ....
06 Jul 2017
Shareholding for the Period Ended June 30, 2017Company Update 
  Exchange Disseminated Time     06/07/2017 16:50:05
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
 
05 Jul 2017
Statement Of Investor Complaints For The Quarter Ended On June 30, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  05/07/2017 15:14:12         Exchange Disseminated Time   05/07/2017 15:14:19              Time Taken   00:00:07
Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statement of Investor Complaints for the Quarter ended June 30, 2017 is attached.
 
27 Jun 2017
Board recommends Final DividendCorp. ActionDownload PDF
  Exchange Disseminated Time     27/06/2017 13:27:30
Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2017, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting.
 
  Outcome of Board MeetingBoard MeetingDownload PDFDownload XBRL
  Exchange Received Time  27/06/2017 13:21:31         Exchange Disseminated Time   27/06/2017 13:21:34              Time Taken   00:00:03
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in their meeting held on June 27, 2017 have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting. ....
Audited Financial Results (Standalone And Consolidated) For The Period Ended On March 31, 2017ResultDownload PDFDownload XBRL
  Exchange Received Time  27/06/2017 13:17:39         Exchange Disseminated Time   27/06/2017 13:17:43              Time Taken   00:00:04
Pursuant to captioned Regulation, please find enclosed herewith a copy of the Audited Financial Results (Standalone and Consolidated) for the period ended on March 31, 2017, as approved by the Board of Directors in their meeting held on even date i.e. June 27, 2017. A copy of the Auditor's Report is also enclosed herewith for your record please. The declaration that audit reports do not contain any modified opinion is also attached.
 

Disclaimer Next >>